March 30 (Reuters) - Valeant Pharmaceuticals International Inc said it was asking its lenders to extend until May 31 the deadline for it to file its annual report, lessening the chance of a default on its $30 billion debt if it misses the current deadline of April 29.
Read more
No comments:
Post a Comment